Clinical Trial Update: Mood Effects of Serotonin Agonists: Depression [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study from the University of Chicago assessing mood-related effects of the serotonin agonist LSD in individuals with Major Depressive Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• LSD (lysergic acid diethylamide)

Snippet

Sponsor: University of Chicago | Conditions: LSD, Major Depressive Disorder | EARLY_Phase 1 | Status: RECRUITING